外科理论与实践 ›› 2024, Vol. 29 ›› Issue (06): 493-497.doi: 10.16139/j.1007-9610.2024.06.06
收稿日期:
2024-10-14
出版日期:
2024-11-25
发布日期:
2025-03-17
通讯作者:
朱越锋,E-mail: srrshzyf@zju.edu.cn基金资助:
CEN Qing1, TANG Mingjun2,3, ZHU Yuefeng2,4()
Received:
2024-10-14
Online:
2024-11-25
Published:
2025-03-17
摘要:
目的: 研究评价下肢静脉曲张病人卵圆孔未闭(PFO)-心内右向左分流(RLS)的发生率。方法: 2023年3月至2024年8月期间连续入住慈溪市人民医院下肢静脉曲张病人86例,其中57例同意行泡沫硬化剂治疗,术前行PFO-RLS检查。结果: 57例中,PFO 23例,发生率为40.4%(95% CI: 27.2%~53.5%),心内RLS 22例,发生率为38.6%(95% CI: 25.6%~51.6%)。PFO发生率高于所报道的普通人群26%。所有病人术后均无肺栓塞、卒中等严重并发症发生。结论: 下肢静脉曲张病人PFO-RLS的发生率高于普通人群的预期水平。下肢静脉曲张病人在选择硬化剂治疗的时候需警惕相关神经系统并发症。
中图分类号:
岑庆, 唐明珺, 朱越锋. 下肢静脉曲张病人卵圆孔未闭-右向左分流发生率的研究[J]. 外科理论与实践, 2024, 29(06): 493-497.
CEN Qing, TANG Mingjun, ZHU Yuefeng. The incidence of PFO-RLS in patients with varicose veins of the lower extremities[J]. Journal of Surgery Concepts & Practice, 2024, 29(06): 493-497.
表1
两组情况对比分析(n/ $\bar{x} \pm s$)
Item | PFO (n=23) | Normality (n=34) | t/χ2 value | P value |
---|---|---|---|---|
Gender (male/female) | 16/7 | 22/12 | 0.146 | >0.05 |
Age(years) | 55.57±12.40 | 57.74±11.56 | -0.675 | >0.05 |
Operating time (min) | 63.04±7.50 | 50.29±8.16 | 5.976 | <0.05 |
Intraoperative blood loss(mL) | 70.87±14.67 | 27.21±11.16 | 12.103 | <0.05 |
Postoperative complication | 2 | 2 | 0 | >0.05 |
[1] |
FORLEE M V, GROUDEN M, MOORE D J, et al. Stroke after varicose vein foam injection sclerotherapy[J]. J Vasc Surg, 2006, 43(1):162-164.
doi: 10.1016/j.jvs.2005.09.032 pmid: 16414404 |
[2] |
KIM M, NIROUMANDPOUR M, POUSTINCHIAN B. Transient ischemic attack after foam sclerotherapy in a woman with a patent foramen ovale[J]. J Am Osteopath Assoc, 2016, 116(5):320-323.
doi: 10.7556/jaoa.2016.063 pmid: 27111786 |
[3] | ABDELHAMID N, FAROOQ S, SARRAJ A. Acute is-chemic stroke in a young woman with no known risk factors[J]. WMJ, 2018, 117(1):42-44. |
[4] |
HOMMA S, SACCO R L. Patent foramen ovale and stroke[J]. Circulation, 2005, 112(7):1063-1072.
pmid: 16103257 |
[5] | WRIGHT D D, GIBSON K D, BARCLAY J, et al. High prevalence of right-to-left shunt in patients with sympto-matic great saphenous incompetence and varicose veins[J]. J Vasc Surg, 2010, 51(1):104-107. |
[6] | GAJO E C, KAVINSKY C J, MURPHY J, et al. The pivotal role of PFO in paradoxical embolism following venous sclerotherapy: a unique case report with pathological correlations[J]. Eur Heart J Case Rep, 2021, 5(8):ytab228. |
[7] | BAHTIRI L, THOMSEN A V, ASHINA M, et al. Migraine aura-like episodes following sclerotherapy for varicose veins of the lower extremities—a systematic review[J]. Headache, 2023, 63(1):40-50. |
[8] | DE MAESENEER M G, KAKKOS S K, AHERNE T, et al. Editor's choice - European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs[J]. Eur J Vasc Endovasc Surg, 2022, 63(2):184-267. |
[9] | GUEX J J, ALLAERT F A, GILLET J L, et al. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions[J]. Dermatol Surg, 2005, 31(2):123-128. |
[10] |
Gillet J L, Guedes J M, Guex J J, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients[J]. Phlebology, 2009, 24(3):131-138.
doi: 10.1258/phleb.2008.008063 pmid: 19470865 |
[11] |
RABE E, BREU F X, CAVEZZI A, et al. European guidelines for sclerotherapy in chronic venous disorders[J]. Phlebology, 2014, 29(6):338-354.
doi: 10.1177/0268355513483280 pmid: 23559590 |
[12] | GIBSON K, KABNICK L. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence[J]. Phlebology, 2017, 32(3):185-193. |
[13] |
REGAN J D, GIBSON K D, RUSH J E, et al. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt[J]. J Vasc Surg, 2011, 53(1):131-137.
doi: 10.1016/j.jvs.2010.06.179 pmid: 20864303 |
[14] | 中华医学会外科学分会血管外科学组. 硬化剂治疗下肢静脉曲张(中国)专家指导意见(2016)[J]. 中国血管外科杂志(电子版), 2017, 9(1):11-14,26. |
Vascular Surgery Group, Chinese Society of Surgery, Chinese Medical Association. Expert guidance on sclerotherapy for varicose veins of the lower extremities (China) (2016)[J]. Chin J Vasc Surg(Electronic Version), 2017, 9(1):11-14,26. | |
[15] | 中华医学会外科学分会血管外科学组, 中国医师协会血管外科医师分会, 中国医疗保健国际交流促进会血管外科分会, 等. 中国慢性静脉疾病诊断与治疗指南[J]. 中华医学杂志, 2019, 99(39):3047-3061. |
CSSG, CAVS, CPAM, et al. Guidelines for the diagnosis and treatment of chronic venous diseases[J]. Natl Med J China, 2019, 99(39):3047-3061. | |
[16] | 中国微循环学会周围血管疾病专业委员会. 聚桂醇注射液治疗下肢静脉曲张微循环专家共识[J]. 血管与腔内血管外科杂志, 2020, 6(5):377-381. |
Chinese Society of Microcirculation & Professional Committee of Vascular Disease. Expert consensus on lauromacrogol injection in the treatment of microcirculation of varicose vein of lower limb[J]. J Vasc Endovasc Surg, 2020, 6(5):377-381. | |
[17] | 中国微循环学会周围血管疾病专业委员会. 原发性下肢浅静脉曲张诊治专家共识(2021版)[J]. 血管与腔内血管外科杂志, 2021, 7(7):762-772. |
Peripheral Vascular Disease Committee of Chinese Socie-ty of Microcirculation. Expert consensus on the diagnosis and treatment of primary superficial varicose veins of the lower extremity (2021 edition)[J]. J Vasc Endovasc Surg, 2021, 7(7):762-772. | |
[18] | 中国医师协会血管外科医师分会静脉学组. 常见静脉疾病诊治规范(2022年版)[J]. 中华血管外科杂志, 2022, 7(1):12-29. |
Chinese Society of Vascular Surgery, Chinese Medical Doctor Association. Diagnosis and treatment standard of common venous diseases (2022 version)[J]. Chin J Vasc Surg, 2022, 7(1):12-29. |
[1] | 丁财有, 吴劲进, 朱越锋. 下肢静脉曲张合并非血栓性髂静脉压迫的诊疗策略[J]. 外科理论与实践, 2024, 29(06): 487-492. |
[2] | 蔡波尔, 朱枫, 柏晓金, 张家雯, 陈湘珺. 基于微信平台的个案管理延伸护理模式在肝硬化合并食管胃底静脉曲张患者中的应用[J]. 内科理论与实践, 2023, 18(05): 344-347. |
[3] | 安宝燕, 郭清, 冯明洋, 徐玉敏, 蔡伟, 谢青, 王晖. aMAP、APRI、FIB-4及肝硬度评估乙型肝炎肝硬化患者食管胃静脉曲张程度的价值探讨[J]. 诊断学理论与实践, 2023, 22(02): 141-146. |
[4] | 张梦茵, 陈平, 袁晓琴, 蔡波尔, 吴云林. 内镜下组织黏合剂联合硬化剂注射治疗胃静脉曲张临床研究及随访[J]. 外科理论与实践, 2022, 27(05): 443-447. |
[5] | 陈星园 张振霖 古文化 周剑国. 低延展性弹力绑带在下肢静脉曲张手术中的应用[J]. 组织工程与重建外科杂志, 2021, 17(4): 343-. |
[6] | 方力, 袁宏涛. 激光腔内闭合术联合泡沫硬化剂注射治疗下肢静脉曲张的临床分析[J]. 外科理论与实践, 2021, 26(04): 367-269. |
[7] | 孙隆慈, 张斌. 门静脉海绵样变致食管胃底静脉曲张的手术治疗(附1例报告)[J]. 外科理论与实践, 2021, 26(03): 226-230. |
[8] | 张斌, 吴志勇. 门静脉高压症食管胃底静脉曲张出血的个体化治疗和手术方式选择[J]. 外科理论与实践, 2021, 26(03): 185-188. |
[9] | 范欣鑫, 吴性江, 何长生. TIPS治疗门静脉高压症伴食管胃底静脉曲张出血的临床价值[J]. 外科理论与实践, 2021, 26(03): 208-211. |
[10] | 胡明礼, 王绮夏, 马雄. 肝硬化食管胃底静脉曲张的药物治疗[J]. 外科理论与实践, 2021, 26(03): 203-207. |
[11] | 李涛, 杨静, 杨红伟, 林环, 王祖辉, 郭娟娟, 朱国献. 外科手术联合腔内技术治疗下肢静脉性溃疡的疗效分析[J]. 外科理论与实践, 2020, 25(04): 336-340. |
[12] | 李敏, 柳俊, 王之倩, 詹维伟. 声脉冲辐射力成像定量技术评估精索静脉曲张非不育患者睾丸组织的研究[J]. 诊断学理论与实践, 2019, 18(05): 543-547. |
[13] | 潘玉琴, 李杨, 茅届齐, 李克, 甘树杰. 内镜深筋膜下穿通静脉离断联合腔内激光治疗下肢静脉曲张[J]. 外科理论与实践, 2018, 23(06): 539-541. |
[14] | 施建平, 张毅, 顾昊, 陈莺, 曹佳, 瞿春莹, 沈峰, 周敏, 徐雷鸣,. 胃静脉曲张黏合剂治疗对门脉高压性胃病的影响[J]. 内科理论与实践, 2017, 12(03): 176-179. |
[15] | 朱炳良, 沙杰. 门脉高压伴不同位置食管胃静脉曲张患者上消化道出血的病因分析及临床意义[J]. 诊断学理论与实践, 2017, 16(01): 114-117. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||